BIOMERIEUX (EPA:BIM)

REGULATED PRESS RELEASE

published on 05/28/2024 at 18:01, 1 year 11 months ago

bioMérieux receives FDA 510(k) clearance of VIDAS® TBI (GFAP, UCH-L1), an innovative test to improve the assessment of patients with mild traumatic brain injury
bioMérieux receives FDA 510(k) clearance of VIDAS TBI (GFAP, UCH-L1), a serum-based test to support the assessment of patients with mild traumatic brain injury, improving patient outcomes. The test uses biomarkers to predict absence of acute intracranial lesions

BioMérieux FDA 510(k) Clearance Biomarkers VIDAS TBI Mild Traumatic Brain Injury
BRIEF

published on 05/23/2024 at 13:07, 1 year 11 months ago

Malawi Ministry of Health, bioMérieux, and Pfizer Form Country's First Multisectoral Collaboration to Address Antimicrobial Resistance

BioMérieux Antimicrobial Resistance Public Health Pfizer Malawi Health
REGULATED PRESS RELEASE

published on 05/23/2024 at 13:02, 1 year 11 months ago

Malawi Ministry of Health, bioMérieux, and Pfizer Form Country’s First Multisectoral Collaboration to Help Address Antimicrobial Resistance
Malawi Ministry of Health, bioMérieux, and Pfizer collaborate to address antimicrobial resistance in Malawi through infection prevention, control, diagnostics, and surveillance. The initiative aims to combat AMR, a global health threat

BioMérieux Antimicrobial Resistance Collaboration Pfizer Malawi Ministry Of Health
BRIEF

published on 05/06/2024 at 17:23, 1 year 11 months ago

BioMérieux financial update: Overview of share capital and voting rights in April 2024

Share Capital Voting Rights BioMérieux Actions In Vitro Diagnostics
BRIEF

published on 04/09/2024 at 07:20, 2 years ago

BioMérieux Outlines Ambitious Five-Year Strategic Growth Plan

Corporate Social Responsibility BioMérieux In Vitro Diagnostics Sustainable Growth GO•28 Strategic Plan
REGULATED PRESS RELEASE

published on 04/09/2024 at 07:15, 2 years ago

bioMérieux presents its new 5-year strategic plan and its targets for profitable growth
bioMérieux unveils its 5-year strategic plan, GO•28, aimed at sustainable growth and responsiblity. Targets include +7% organic revenue growth and -50% GHG emissions by 2030

BioMérieux Strategic Plan Organic Growth GHG Emissions GO•28
BRIEF

published on 04/09/2024 at 07:06, 2 years ago

BioMérieux Posts Strong First-Quarter 2024 Results with Outstanding Sales Growth

BioMérieux In Vitro Diagnostics First-Quarter 2024 BIOFIRE® Panels SPOTFIRE®
REGULATED PRESS RELEASE

published on 04/09/2024 at 07:01, 2 years ago

bioMérieux – First-Quarter 2024 Business Review
bioMérieux reports strong +10% organic sales growth in the first quarter of 2024, driven by BIOFIRE® and microbiology segments. Sales reach €965 million. Company confirms 2024 guidance for sales and operating profit

BioMérieux Organic Sales Growth 2024 Guidance BIOFIRE® Microbiology
BRIEF

published on 04/05/2024 at 09:04, 2 years 1 month ago

BioMérieux announces its number of shares and voting rights for March 2024

Share Capital Voting Rights BioMérieux Actions March 2024
BRIEF

published on 04/05/2024 at 07:06, 2 years 1 month ago

BioMérieux and Mérieux NutriSciences Launch Collaborative Data-Driven Initiative for Food Safety

BioMérieux Food Safety Industry Collaboration Data-driven Initiative Consumer Safety

Published on 05/06/2026 at 02:17, 4 hours 13 minutes ago

Troubadour Announces Share Consolidation and Effective Date
Published on 05/06/2026 at 02:00, 4 hours 30 minutes ago

Vanta Announces Closing of First Tranche of Private Placement and Debt Settlement
Published on 05/06/2026 at 02:00, 4 hours 30 minutes ago

Alset AI Announces Shares for Debt Transaction
Published on 05/06/2026 at 01:30, 5 hours ago

Presentation to RIU Sydney Resources Roundup
Published on 05/06/2026 at 01:20, 5 hours 10 minutes ago

Empress Grants Stock Options and Equity Incentives

View all ACCESSWIRE

Published on 05/06/2026 at 06:00, 30 minutes ago

Moody’s upgrades HDBank’s outlook to 'Positive,' paving the way for potential credit rating upgrade
Published on 05/06/2026 at 03:05, 3 hours 24 minutes ago

ARC Group Advises Magnax on €35.5 Million Strategic Investment from Pan-International Industrial Corp. and Foxconn Group
Published on 05/06/2026 at 03:05, 3 hours 24 minutes ago

Bank of America Convenes Global Leaders in Asia Pacific for its Breakthrough Technology Dialogue
Published on 05/06/2026 at 01:35, 4 hours 54 minutes ago

VERNAL CAPITAL ACQUISITION CORP. ANNOUNCES PRICING OF $100 MILLION INITIAL PUBLIC OFFERING
Published on 05/06/2026 at 00:05, 6 hours 24 minutes ago

ESOC 2026: Rising stroke rates highlight widening ethnic and socioeconomic inequalities across populations, major study finds

View all EQS

Published on 05/05/2026 at 19:00, 11 hours 30 minutes ago

Combined General Meeting of Air Liquide Shareholders of May 5, 2026
Published on 05/05/2026 at 18:40, 11 hours 50 minutes ago

Share Buyback program
Published on 05/05/2026 at 18:03, 12 hours 27 minutes ago

Aéroports de Paris SA - Shares and voting rights as of 30 April 2026
Published on 05/05/2026 at 17:56, 12 hours 34 minutes ago

NRJ GROUP - Financial Information Q1 2026
Published on 05/05/2026 at 17:53, 12 hours 36 minutes ago

TF1 - Monthly disclosure of the total number of shares and voting rights - April 2026

View all LES ECHOS COMFI WIRE

News